Epstein Jonathan I, Amin Mahul, Boccon-Gibod Liliane, Egevad Lars, Humphrey Peter A, Mikuz Gregor, Newling Don, Nilsson Sten, Sakr Wael, Srigley John R, Wheeler Thomas M, Montironi Rodolfo
Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland 21231, USA.
Scand J Urol Nephrol Suppl. 2005 May(216):34-63. doi: 10.1080/03008880510030932.
This paper, based on the activity of the Morphology-Based Prognostic Factors Committee of the 2004 World Health Organization-sponsored International Consultation, describes various methods of handling radical prostatectomy specimens for both routine clinical use and research purposes. The correlation between radical prostatectomy findings and postoperative failure is discussed in detail. This includes issues relating to pelvic lymph node involvement, detected both at the time of frozen section and in permanent sections. Issues of seminal vesicle invasion, including its definition, routes of invasion and relationship to prognosis, are covered in detail. The definition, terminology and incidence of extra-prostatic extension are elucidated, along with its prognostic significance relating to location and extent. Margins of resection are covered in terms of their definition, the etiology, incidence and sites of positive margins, the use of frozen sections to assess the margins and the relationship between margin positivity and prognosis. Issues relating to grade within the radical prostatectomy specimen are covered in depth, including novel ways of reporting Gleason grade and the concept of tertiary Gleason patterns. Tumor volume, tumor location, vascular invasion and perineural invasion are the final variables discussed relating to the prognosis of radical prostatectomy specimens. The use of multivariate analysis to predict progression is discussed, together with proposed modifications to the TNM system. Finally, biomarkers to predict progression following radical prostatectomy are described, including DNA ploidy, microvessel density, Ki-67, neuroendocrine differentiation, p53, p21, p27, Bcl-2, Her-2/neu, E-cadherin, CD44, retinoblastoma proteins, apoptotic index, androgen receptor status, expression of prostate-specific antigen and prostatic-specific acid phosphatase and nuclear morphometry.
本文基于2004年世界卫生组织主办的国际咨询会议形态学预后因素委员会的活动,描述了用于常规临床和研究目的的根治性前列腺切除术标本的各种处理方法。详细讨论了根治性前列腺切除术结果与术后失败之间的相关性。这包括与盆腔淋巴结受累相关的问题,在冰冻切片和永久切片时均有检测。详细涵盖了精囊侵犯的问题,包括其定义、侵犯途径及其与预后的关系。阐明了前列腺外扩展的定义、术语和发生率,以及其与位置和范围相关的预后意义。从切缘的定义、阳性切缘的病因、发生率和部位、使用冰冻切片评估切缘以及切缘阳性与预后的关系等方面对切缘进行了阐述。深入探讨了根治性前列腺切除术标本中的分级问题,包括报告Gleason分级的新方法和三级Gleason模式的概念。肿瘤体积、肿瘤位置、血管侵犯和神经周围侵犯是最后讨论的与根治性前列腺切除术标本预后相关的变量。讨论了使用多变量分析预测进展情况,以及对TNM系统的建议修改。最后,描述了预测根治性前列腺切除术后进展的生物标志物,包括DNA倍体、微血管密度、Ki-67、神经内分泌分化、p53、p21、p27、Bcl-2、Her-2/neu、E-钙黏蛋白、CD44、视网膜母细胞瘤蛋白、凋亡指数、雄激素受体状态、前列腺特异性抗原和前列腺特异性酸性磷酸酶的表达以及核形态测量。